Sodium glucose cotransporter-2 inhibitors: Are we targeting old devil with new problems?

Venu Gopal Jonnalagadda; Kanchan Choudhary; Vijay Kranti Matety

首页> 中文期刊> 《亚太热带生物医学杂志：英文版》 >Sodium glucose cotransporter-2 inhibitors: Are we targeting old devil with new problems?

Sodium glucose cotransporter-2 inhibitors: Are we targeting old devil with new problems?

开具论文收录证明 >>

期刊封面封底目录下载 >>

文献代查 >>

页面导航

摘要
著录项
相关主题

摘要

<正>Dear editor,The advent of modern molecular mechanism’s approach to disease treatment is highly advancing to mitigate/normalize the symptoms of disease i.e.hyperglycemia by targeting at least eight different pathophysiological approaches popularly known as omnious octet[1].Importantly,type 2 diabetes is a metabolic

著录项

来源
《亚太热带生物医学杂志：英文版》 |2017年第011期|P.1023-1024|共2页
作者
Venu Gopal Jonnalagadda; Kanchan Choudhary; Vijay Kranti Matety;
展开▼
作者单位

Department of Pharmacology & Toxicology, National Institute of Pharmaceutical Education and Research;

Department of Pharmacology & Toxicology, Bhupal Nobles’ Institute of Pharmaceutical Sciences;

Department of Pharmacology & Toxicology, National Institute of Pharmaceutical Education and Research;

Department of Pharmacology & Toxicology, Bhupal Nobles’ Institute of Pharmaceutical Sciences;

Department of Pharmacology & Toxicology, National Institute of Pharmaceutical Education and Research;

Department of Pharmacology & Toxicology, Bhupal Nobles’ Institute of Pharmaceutical Sciences;

展开▼
原文格式 PDF
正文语种 CHI
中图分类 R977.15;
关键词

Sodium glucose cotransporter-2 inhibitors: Are we targeting old devil with new problems?

摘要

著录项

相关主题

期刊订阅